Details

We are looking for immediate Distribution, Supply Chain Representatives and/or Investor/Entrepreneurs to invest in or acquire a very needed Vaccine Alternative called TryNovid. This product and it’s ingredients are documented to fight and kill lipid coated viruses like Covid.

The ingredients in TryNOVID® has no competition, offering a proprietary blend that promotes a synergistic and overall health benefit in each capsule.

TryNOVID® contains ingredients that are also effective at killing 99.9% of both Bacteria and Viruses.

TryNOVID® is effective against other lipid coated viruses.

The territory that we cover is the United States. In a broader sense: North and South America. We have Sub Distribution Opportunities Available (Limited Opportunity)

The following characteristics are desirable: 

- Located in the US (North or South America)

- The ability to obtain 1000-8000 or more units of TryNovid for distribution to established networks of supply chains, brokers, businesses and facilities that can service the public in this global crisis. Note: This product is perfect to address helping both the Vaccinated and the Unvaccinated with a very needed healthy option that protects the body, not hurt the body. Saving Lives is the Key.

- The capacity and ability to distribute in bulk to supply chains or vendors.

- TryNovid Highlights: Contains natural antiviral supplements that fight and kill Covid TryNOVID® is a food supplement designed to support the normal function of the immune system. To create new strategies that reduce the impact of the pandemic caused by the SARS-CoV-2 in our society. TryNOVID® is produced and sold as a food supplement in compliance with relevant European and American food supplement regulations.

Learn More

Sign up for a free membership. Get instant access to thousands of listings. Learn about our membership plans.

Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum.